268 related articles for article (PubMed ID: 23288238)
1. A case of high-dose venlafaxine-related psychosis.
Dennison EA; Raidoo BM; Cruz R; Raidoo D
J Clin Psychopharmacol; 2013 Feb; 33(1):134-6. PubMed ID: 23288238
[No Abstract] [Full Text] [Related]
2. Use of bupropion with SRIs and venlafaxine.
Spier SA
Depress Anxiety; 1998; 7(2):73-5. PubMed ID: 9614595
[TBL] [Abstract][Full Text] [Related]
3. Venlafaxine-associated nocturnal bruxism in a depressive patient successfully treated with buspirone.
Kuloglu M; Ekinci O; Caykoylu A
J Psychopharmacol; 2010 Apr; 24(4):627-8. PubMed ID: 19264817
[No Abstract] [Full Text] [Related]
4. Acute adverse cutaneous reaction after the concomitant use of venlafaxine and orphenadrine citrate plus paracetamol in a depressed patient.
Papadimitriou GN; Theleritis CG; Papageorgiou CC; Kalogeromitros D; Syrigou E; Gregoriou S; Rabavilas AD
J Eur Acad Dermatol Venereol; 2006 Sep; 20(8):1019. PubMed ID: 16922966
[No Abstract] [Full Text] [Related]
5. Differential physiological effects of a low dose and high doses of venlafaxine in major depression.
Debonnel G; Saint-André E; Hébert C; de Montigny C; Lavoie N; Blier P
Int J Neuropsychopharmacol; 2007 Feb; 10(1):51-61. PubMed ID: 16690006
[TBL] [Abstract][Full Text] [Related]
6. Successful duloxetine use to prevent venlafaxine withdrawal symptoms.
Hsiao MC; Liu CY
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):576. PubMed ID: 17889418
[No Abstract] [Full Text] [Related]
7. Venlafaxine-induced serotonin syndrome with relapse following amitriptyline.
Perry NK
Postgrad Med J; 2000 Apr; 76(894):254-6. PubMed ID: 10727586
[TBL] [Abstract][Full Text] [Related]
8. The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression: a meta-analysis.
Bauer M; Tharmanathan P; Volz HP; Moeller HJ; Freemantle N
Eur Arch Psychiatry Clin Neurosci; 2009 Apr; 259(3):172-85. PubMed ID: 19165525
[TBL] [Abstract][Full Text] [Related]
9. Quetiapine adjunct to selective serotonin reuptake inhibitors or venlafaxine in patients with major depression, comorbid anxiety, and residual depressive symptoms: a randomized, placebo-controlled pilot study.
McIntyre A; Gendron A; McIntyre A
Depress Anxiety; 2007; 24(7):487-94. PubMed ID: 17177199
[TBL] [Abstract][Full Text] [Related]
10. A possible case of venlafaxine-induced Stevens-Johnson syndrome.
Weiss NT; Jones L; Chamberlain JC
J Clin Psychiatry; 2004 Oct; 65(10):1431-3. PubMed ID: 15491252
[No Abstract] [Full Text] [Related]
11. Serotonin syndrome and rhabdomyolysis in venlafaxine poisoning: a case report.
Hanekamp BB; Zijlstra JG; Tulleken JE; Ligtenberg JJ; van der Werf TS; Hofstra LS
Neth J Med; 2005 Sep; 63(8):316-8. PubMed ID: 16186642
[TBL] [Abstract][Full Text] [Related]
12. Biological perspectives. Serotonin and norepinephrine reuptake inhibitors (SNRIs): venlafaxine and duloxetine.
Lee SI; Keltner NL
Perspect Psychiatr Care; 2006 May; 42(2):144-8. PubMed ID: 16677140
[No Abstract] [Full Text] [Related]
13. [Discontinuation of antidepressant serotonergic antidepressant].
Andersen CL; Videbech P
Ugeskr Laeger; 2010 Jan; 172(4):296-8. PubMed ID: 20105399
[TBL] [Abstract][Full Text] [Related]
14. Escitalopram versus serotonin noradrenaline reuptake inhibitors as second step treatment for patients with major depressive disorder: a pooled analysis.
Lam RW; Lönn SL; Despiégel N
Int Clin Psychopharmacol; 2010 Jul; 25(4):199-203. PubMed ID: 20357664
[TBL] [Abstract][Full Text] [Related]
15. Photodistributed eruptive telangiectasia: an uncommon adverse drug reaction to venlafaxine.
Vaccaro M; Borgia F; Barbuzza O; Guarneri B
Br J Dermatol; 2007 Oct; 157(4):822-4. PubMed ID: 17655739
[No Abstract] [Full Text] [Related]
16. Dose-related paresthesias with venlafaxine.
Angelo LJ; Lee KC
J Pharm Pract; 2013 Oct; 26(5):514-7. PubMed ID: 23764565
[TBL] [Abstract][Full Text] [Related]
17. Serotonin-norepinephrine reuptake inhibitor therapy in late-life depression is associated with increased marker of bone resorption.
Shea ML; Garfield LD; Teitelbaum S; Civitelli R; Mulsant BH; Reynolds CF; Dixon D; Doré P; Lenze EJ
Osteoporos Int; 2013 May; 24(5):1741-9. PubMed ID: 23358607
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.
Kennedy SH; Andersen HF; Lam RW
J Psychiatry Neurosci; 2006 Mar; 31(2):122-31. PubMed ID: 16575428
[TBL] [Abstract][Full Text] [Related]
19. Hemorrhages during escitalopram-venlafaxine-mirtazapine combination treatment of depression.
Benazzi F
Can J Psychiatry; 2005 Mar; 50(3):184. PubMed ID: 15830829
[No Abstract] [Full Text] [Related]
20. Venlafaxine versus SSRI therapy for major depression. Results of comparative efficacy trials.
Bakish D
Postgrad Med; 1999 Nov; 106(6 Suppl):24-30. PubMed ID: 19667501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
